Page last updated: 2024-11-07

prednisone and Mesenchymoma

prednisone has been researched along with Mesenchymoma in 2 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Mesenchymoma: A mixed mesenchymal tumor composed of two or more mesodermal cellular elements not commonly associated, not counting fibrous tissue as one of the elements. Mesenchymomas are widely distributed in the body and about 75% are malignant. (Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Emmertsen, K1
Sharma, TC1
Huvos, AG1
Grabstald, H1

Other Studies

2 other studies available for prednisone and Mesenchymoma

ArticleYear
[Spontaneous hypoglycemia with mesenchymal tumor of the liver].
    Ugeskrift for laeger, 1978, Dec-11, Volume: 140, Issue:50

    Topics: Aged; Female; Glucagon; Humans; Hypoglycemia; Liver Neoplasms; Mesenchymoma; Prednisone

1978
Retroperitoneal malignant mesenchymoma.
    The Journal of urology, 1971, Volume: 106, Issue:1

    Topics: Adult; Aortography; Child, Preschool; Cyclophosphamide; Dactinomycin; Female; Humans; Male; Melphala

1971